Please assess the completion status of the following clinical trial:

Trial Title: A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 19\~45 years in healthy volunteers~2. BMI is more than 18.5 kg/m\^2 , no more than 29.9 kg/m\^2~3. Subjects who agree to use medically accepted dual contraceptives up to two months after the last administration date of the clinical trial drug and not to provide sperm.~4. Subjects who have ability to comprehend the objectives, contents of study and property of study drug before participating in trial and have willingness to sign of informed consent in writing~Exclusion Criteria:~1. Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in digestive system, neuropsychiatric system, endocrine system, liver, cardiovascular system~2. Subjects who judged ineligible by the investigator

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Sequence 1 (Reference-Test) (Type: EXPERIMENTAL): Period1: HCP1306+HGP0904+HGP0608, Period 2: HCP1701
- Sequence 2 (Test-Reference) (Type: EXPERIMENTAL): Period1: HCP1701, Period 2: HCP1306+HGP0904+HGP0608

Based on this trial design, predict the completion outcome and termination type (if applicable).